-
Jury awards Burford-funded Taction $5.7B against Apple, but verdict appears not too likely to be affirmed; even JMOL appears possible
Read more: Jury awards Burford-funded Taction $5.7B against Apple, but verdict appears not too likely to be affirmed; even JMOL appears possibleIt will not be easy to defend this record patent damages verdict, given not only its outsized amount but also the deficiencies of the record that Apple has already alleged.
-
French consumer rights group urges Disney+ to compensate customers for switching off 4K following InterDigital injunctionsÂ
Read more: French consumer rights group urges Disney+ to compensate customers for switching off 4K following InterDigital injunctionsÂWhile Disney+ switched 4K back on again using a workaround in Germany, the streaming giant has not done the same in its other markets, including France.
-
Mylan seeks declaratory judgment against Novo Nordisk over newly issued Wegovy patent, aiming to preempt a new Delaware lawsuit
Read more: Mylan seeks declaratory judgment against Novo Nordisk over newly issued Wegovy patent, aiming to preempt a new Delaware lawsuitMylan has asked a Delaware court to declare a newly issued Novo Nordisk Wegovy patent invalid and not infringed, opening a new front in their long-running Hatch-Waxman fight over generic semaglutide.
-
EPO board of appeal rejects claim-saving approach to ambiguous amendments
Read more: EPO board of appeal rejects claim-saving approach to ambiguous amendmentsThe EPO Board of Appeal has rejected a claim-saving approach to ambiguous amendments in a Philip Morris e-cigarette patent dispute, holding that unresolved ambiguity can broaden a claim and create added-matter problems.Â
-
Collective hold-out by makers of smart meters may have been primary reason for demise of Avanci’s related licensing program
Read more: Collective hold-out by makers of smart meters may have been primary reason for demise of Avanci’s related licensing programAvanci IoT, a licensing program primarily for smart meters, had 45 licensors and 3 licensees, but has apparently been stopped.
-
Qualcomm, Apple announce renewal of license agreement that was set to expire next spring: details unknown
Read more: Qualcomm, Apple announce renewal of license agreement that was set to expire next spring: details unknownNo details are known, but this is likely one of the largest patent license deals in the industry.
-
Federal court dismisses Entresto antitrust suit against Novartis: patent listing in Orange Book was proper
Read more: Federal court dismisses Entresto antitrust suit against Novartis: patent listing in Orange Book was properJudge Liman held that the U.S. Patent No. 8,101,659 claims the active ingredients on Entresto’s FDA label, so its Orange Book listing was proper, ending a payor’s antitrust case with prejudice.
-
UPC Brussels limits interveners’ ability to pursue independent claims
Read more: UPC Brussels limits interveners’ ability to pursue independent claimsThe UPC’s Brussels LD has rejected the NIH’s bid to be treated as a co-claimant in 2seventy Bio’s infringement case, holding that interveners are limited to supporting the claims of the party they join and cannot pursue an independent litigation position.
Follow Us
Latest Articles
- Jury awards Burford-funded Taction $5.7B against Apple, but verdict appears not too likely to be affirmed; even JMOL appears possible
- French consumer rights group urges Disney+ to compensate customers for switching off 4K following InterDigital injunctionsÂ
- Mylan seeks declaratory judgment against Novo Nordisk over newly issued Wegovy patent, aiming to preempt a new Delaware lawsuit
- EPO board of appeal rejects claim-saving approach to ambiguous amendments
- Collective hold-out by makers of smart meters may have been primary reason for demise of Avanci’s related licensing program